About Shana Kelley
Form D filings for CTRL Therapeutics USA from 2022 to 2024 list Shana Kelley as executive officer and director.
Shana Kelley first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Shana Kelley in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shana Kelley works with at each company, as listed on that company's latest Form D.
CTRL Therapeutics USA, Inc. · Form D, Sep 27, 2024